Robotic-assisted Neuroendovascular Aneurysm Embolization Shows Promising 6-month Results

The six-month follow-up results from nan pioneering proceedings of robotic-assisted neuroendovascular aneurysm embolization utilizing nan CorPath GRX strategy were presented coming by Vitor Pereira, MD connected behalf of nan investigators astatine nan Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting.

The adjudicated six-month results from nan prospective, single-arm, international, multicenter, non-inferiority study demonstrated information and effectiveness of robotic-assisted neuroendovascular aneurysm embolization. These results correspond a important milestone, arsenic they represent nan only published mid-term objective follow-up information to day connected robotic-assisted neuroendovascular aneurysm embolization.

The study enrolled 117 patients crossed 10 objective sites and was conducted by 14 neurointerventionalists spanning six countries. It included some a premarket study successful Canada and post-market studies successful Australia, Austria, France, Spain and Switzerland.

Key findings of nan study include:

• A 94% method occurrence rate, achieving nan superior effectiveness endpoint defined arsenic successful completion of nan robotic-assisted neuroendovascular process without unplanned conversions to manual intervention.
• Immediate complete occlusion (RROC 1) of 64.5% accrued to 94.1% astatine six months.
• Favorable objective outcomes (modified Rankin Scale people 0–2) were observed successful 98.9% (87/88) of patients astatine six months.

"The six-month results of nan CorPath GRX proceedings correspond a important measurement guardant successful nan improvement of neuroendovascular robotics and will play a cardinal domiciled successful shaping early invention successful nan section of neuroendovascular therapy. I americium excited to stock this news pinch nan community," said Dr. Pereira. "It shows that robotics successful neuroendovascular interventions could supply precision and support to nan expert moreover successful navigating tortuous anatomy and curen of analyzable aneurysm cases."

The neuroendovascular robotic-assisted CorPath GRX proceedings was sponsored by Siemens Healthineers Endovascular Robotics, Inc. Siemens Healthineers continues to put successful nan improvement of their next-generation neurendoovascular robotic platform.